Nadia Bahmad is currently the Market Access & Public Affairs Director at CSL Behring in France. They previously served as the National Market Access Leader at Roche, where they defined and implemented access and pricing strategies for various therapies. From 2014 to 2016, they were the Head of the Innovation and Development Pole at the ANSM, responsible for evaluating clinical trials and representing the agency in European discussions. Nadia's educational background includes a Master’s in Health Law and Management, as well as various post-graduate diplomas related to pharmacoeconomics and clinical trial interpretation.
This person is not in any teams
This person is not in any offices